Silverarc Capital Management as of June 30, 2022
Portfolio Holdings for Silverarc Capital Management
Silverarc Capital Management holds 68 positions in its portfolio as reported in the June 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) | 14.0 | $46M | 163k | 280.28 | |
Intra Cellular Therapies (ITCI) | 5.5 | $18M | 314k | 57.08 | |
Spdr Ser Tr S&p Biotech Call Option (XBI) | 4.8 | $16M | 208k | 74.27 | |
Bellus Health Com New | 4.4 | $14M | 1.6M | 9.24 | |
Veracyte (VCYT) | 4.4 | $14M | 719k | 19.90 | |
Cerus Corporation (CERS) | 3.4 | $11M | 2.1M | 5.29 | |
Merus N V (MRUS) | 3.3 | $11M | 469k | 22.64 | |
Mirati Therapeutics | 2.8 | $9.2M | 137k | 67.14 | |
Anavex Life Sciences Corp Com New Put Option (AVXL) | 2.8 | $9.2M | 917k | 10.01 | |
Morphic Hldg (MORF) | 2.8 | $9.1M | 419k | 21.70 | |
Female Health Put Option (VERU) | 2.7 | $8.8M | 780k | 11.30 | |
Prometheus Biosciences Put Option | 2.6 | $8.5M | 302k | 28.23 | |
Cti Biopharma | 2.5 | $8.2M | 1.4M | 5.97 | |
Aclaris Therapeutics (ACRS) | 2.3 | $7.5M | 540k | 13.96 | |
Cogent Biosciences (COGT) | 2.3 | $7.4M | 821k | 9.02 | |
Seagen | 2.2 | $7.2M | 41k | 176.94 | |
Xenon Pharmaceuticals (XENE) | 2.2 | $7.1M | 233k | 30.42 | |
Krystal Biotech (KRYS) | 2.1 | $6.9M | 105k | 65.66 | |
Apellis Pharmaceuticals (APLS) | 1.8 | $5.9M | 130k | 45.22 | |
Alnylam Pharmaceuticals Call Option (ALNY) | 1.8 | $5.8M | 40k | 145.85 | |
Horizon Therapeutics Pub L SHS | 1.8 | $5.8M | 72k | 79.77 | |
Oric Pharmaceuticals (ORIC) | 1.5 | $4.8M | 1.1M | 4.48 | |
Contrafect Corp Com New Put Option | 1.5 | $4.8M | 1.6M | 3.07 | |
Biogen Idec (BIIB) | 1.3 | $4.2M | 21k | 203.94 | |
Insmed Com Par $.01 (INSM) | 1.3 | $4.2M | 213k | 19.72 | |
Iveric Bio Put Option | 1.3 | $4.1M | 431k | 9.62 | |
Mersana Therapeutics (MRSN) | 1.2 | $3.9M | 850k | 4.62 | |
Apollo Endosurgery | 1.2 | $3.9M | 1.1M | 3.65 | |
Biohaven Pharmaceutical Holding | 1.2 | $3.8M | 26k | 145.71 | |
United Therapeutics Corporation (UTHR) | 1.2 | $3.8M | 16k | 235.66 | |
Immatics SHS (IMTX) | 1.0 | $3.1M | 355k | 8.71 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.9 | $2.9M | 10k | 281.83 | |
Cullinan Oncology (CGEM) | 0.8 | $2.7M | 213k | 12.82 | |
Crinetics Pharmaceuticals In (CRNX) | 0.8 | $2.6M | 140k | 18.65 | |
Regenxbio Inc equity us cm (RGNX) | 0.8 | $2.6M | 104k | 24.70 | |
Akero Therapeutics (AKRO) | 0.8 | $2.5M | 260k | 9.45 | |
Otonomy | 0.7 | $2.2M | 1.0M | 2.08 | |
Eliem Therapeutics (ELYM) | 0.7 | $2.2M | 713k | 3.02 | |
Syndax Pharmaceuticals (SNDX) | 0.6 | $2.1M | 108k | 19.24 | |
Phreesia (PHR) | 0.6 | $2.0M | 78k | 25.02 | |
Celldex Therapeutics Com New Put Option (CLDX) | 0.6 | $2.0M | 72k | 26.97 | |
Viewray (VRAYQ) | 0.6 | $1.9M | 733k | 2.65 | |
Day One Biopharmaceuticals I (DAWN) | 0.6 | $1.9M | 106k | 17.90 | |
ImmunoGen | 0.6 | $1.9M | 417k | 4.50 | |
CVRX (CVRX) | 0.5 | $1.8M | 292k | 6.01 | |
Eyepoint Pharmaceuticals Com New (EYPT) | 0.5 | $1.6M | 198k | 7.87 | |
Codexis (CDXS) | 0.4 | $1.4M | 138k | 10.46 | |
Humanigen Com New Put Option (HGENQ) | 0.4 | $1.4M | 781k | 1.77 | |
Nkarta (NKTX) | 0.4 | $1.4M | 111k | 12.32 | |
Amryt Pharma Sponsored Ads | 0.4 | $1.2M | 176k | 6.99 | |
Seres Therapeutics (MCRB) | 0.4 | $1.2M | 348k | 3.43 | |
Ngm Biopharmaceuticals (NGM) | 0.3 | $1.1M | 88k | 12.82 | |
Zymeworks | 0.3 | $1.1M | 208k | 5.30 | |
Poseida Therapeutics I (PSTX) | 0.3 | $982k | 381k | 2.58 | |
Silverback Therapeutics (SPRY) | 0.3 | $887k | 209k | 4.24 | |
Polypid SHS | 0.2 | $750k | 162k | 4.64 | |
Stereotaxis Com New (STXS) | 0.2 | $678k | 369k | 1.84 | |
Forma Therapeutics Hldgs SHS | 0.2 | $650k | 94k | 6.89 | |
Chemocentryx | 0.2 | $645k | 26k | 24.77 | |
BioCryst Pharmaceuticals (BCRX) | 0.2 | $566k | 54k | 10.58 | |
Meiragtx Holdings (MGTX) | 0.1 | $394k | 52k | 7.57 | |
Eloxx Pharmaceuticals | 0.1 | $281k | 1.0M | 0.27 | |
Compugen Ord (CGEN) | 0.1 | $193k | 104k | 1.85 | |
Mereo Biopharma Group Ads (MREO) | 0.1 | $175k | 156k | 1.12 | |
Evogene SHS (EVGN) | 0.0 | $156k | 202k | 0.77 | |
Aligos Therapeutics (ALGS) | 0.0 | $71k | 58k | 1.22 | |
Medicus Sciences Acquisition *w Exp 02/12/202 | 0.0 | $9.0k | 50k | 0.18 | |
Renovacor *w Exp 99/99/999 | 0.0 | $6.0k | 105k | 0.06 |